These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

928 related items for PubMed ID: 8996133

  • 1. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
    [Abstract] [Full Text] [Related]

  • 2. [Recent improvements in antiemetic therapy].
    Roila F, Palladino MA, Ciccarese G, Basurto C.
    Tumori; 1997 Jan; 83(2 Suppl):S3-14. PubMed ID: 9235727
    [Abstract] [Full Text] [Related]

  • 3. Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1993 Dec; 11(12):2396-404. PubMed ID: 8246029
    [Abstract] [Full Text] [Related]

  • 4. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
    Lancet; 1992 Jul 11; 340(8811):96-9. PubMed ID: 1352024
    [Abstract] [Full Text] [Related]

  • 5. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
    Support Care Cancer; 2000 May 11; 8(3):229-32. PubMed ID: 10789965
    [Abstract] [Full Text] [Related]

  • 6. Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination.
    Roila F.
    Oncology; 1993 May 11; 50(3):163-7. PubMed ID: 8459986
    [Abstract] [Full Text] [Related]

  • 7. A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Ondansetron Delayed Emesis Study Group.
    Olver I, Paska W, Depierre A, Seitz JF, Stewart DJ, Goedhals L, McQuade B, McRae J, Wilkinson JR.
    Ann Oncol; 1996 Nov 11; 7(9):945-52. PubMed ID: 9006746
    [Abstract] [Full Text] [Related]

  • 8. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
    Manusirivithaya S, Chareoniam V, Isariyodom P, Sungsab D.
    J Med Assoc Thai; 2001 Jul 11; 84(7):966-72. PubMed ID: 11759977
    [Abstract] [Full Text] [Related]

  • 9. Randomized, double-blinded, placebo-controlled trial of ondansetron plus dexamethasone with or without metoclopramide as antiemetic prophylaxis in patients receiving high-dose cisplatin in medical practice.
    Ithimakin S, Runglodvatana K, Nimmannit A, Akewanlop C, Srimuninnimit V, Keerativitayanan N, Soparattanapaisarn N, Laocharoenkeat A.
    Support Care Cancer; 2012 Apr 11; 20(4):849-55. PubMed ID: 21505898
    [Abstract] [Full Text] [Related]

  • 10. Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis.
    Bhatia A, Tripathi KD, Sharma M.
    Indian J Med Res; 2004 Sep 11; 120(3):183-93. PubMed ID: 15489556
    [Abstract] [Full Text] [Related]

  • 11. Double-blind, dose-finding study of four intravenous doses of dexamethasone in the prevention of cisplatin-induced acute emesis. Italian Group for Antiemetic Research.
    J Clin Oncol; 1998 Sep 11; 16(9):2937-42. PubMed ID: 9738561
    [Abstract] [Full Text] [Related]

  • 12. Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy.
    Italian Group for Antiemetic Research.
    N Engl J Med; 2000 May 25; 342(21):1554-9. PubMed ID: 10824073
    [Abstract] [Full Text] [Related]

  • 13. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG.
    Semin Oncol; 1994 Oct 25; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
    Bhatia A, Tripathi KD, Sharma M.
    Indian J Med Res; 2003 Jul 25; 118():33-41. PubMed ID: 14748464
    [Abstract] [Full Text] [Related]

  • 16. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.
    Hainsworth J, Harvey W, Pendergrass K, Kasimis B, Oblon D, Monaghan G, Gandara D, Hesketh P, Khojasteh A, Harker G.
    J Clin Oncol; 1991 May 25; 9(5):721-8. PubMed ID: 1826739
    [Abstract] [Full Text] [Related]

  • 17. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
    Kris MG, Gralla RJ, Tyson LB, Clark RA, Cirrincione C, Groshen S.
    J Clin Oncol; 1989 Jan 25; 7(1):108-14. PubMed ID: 2642536
    [Abstract] [Full Text] [Related]

  • 18. Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study.
    Roila F, Ruggeri B, Ballatori E, Fatigoni S, Caserta C, Licitra L, Mirabile A, Ionta MT, Massidda B, Cavanna L, Palladino MA, Tocci A, Fava S, Colantonio I, Angelelli L, Ciuffreda L, Fasola G, Zerilli F.
    Ann Oncol; 2015 Jun 25; 26(6):1248-1253. PubMed ID: 25743855
    [Abstract] [Full Text] [Related]

  • 19. Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesis.
    Kris MG, Tyson LB, Clark RA, Gralla RJ.
    Cancer; 1992 Aug 15; 70(4 Suppl):1012-6. PubMed ID: 1386282
    [Abstract] [Full Text] [Related]

  • 20. Comparison of two different doses of ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced emesis.
    Pectasides D, Mylonakis A, Varthalitis J, Kostopoulou M, Constantinou A, Papazachariou K, Antoniou F, Dimitriadis M, Athanassiou A.
    Oncology; 1997 Aug 15; 54(1):1-6. PubMed ID: 8978584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.